Relative Strength Chart Sarepta Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 08:20:10 16/07/2026 pm IST			5-day change	1st Jan Change
17.57 ^USD	-0.23%		-14.69%	-18.66%

30/06	Sarepta Therapeutics Announces FDA Acceptance Of Supplemental New Drug Applications For Amondys 45 And Vyondys 53 For Duchenne Muscular Dystrophy	CI
30/06	Sarepta Therapeutics Gets FDA Review for Duchenne Muscular Dystrophy Applications	MT

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	SAREPTA THERAPEUTICS, INC.	Diagnostic & Testing Substances Manufacturers	-0.71%	-14.69%	-18.66%	-4.76%	-73.89%	185.92Cr